This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
|
Luke Pyungse Lee | |
---|---|
Born | March 22, 1959 |
Nationality | American |
Alma mater | University of California, Berkeley |
Known for | bionanophotonics, microfluidics, optofluidics, molecular diagnostics, nanomedicine, |
Awards | 2003 National Science Foundation Career Award 2005 Lester John and Lynne Dewar Lloyd Distinguished Professorship |
Scientific career | |
Fields | Biophysics, Bioengineering, Electrical Engineering and Computer Science |
Institutions | National University of Singapore |
Korean name | |
Hangul | 이평세 |
Revised Romanization | I Pyeong-se |
McCune–Reischauer | I P'yŏngse |
Luke Pyungse Lee (born March 22, 1959) is the Arnold and Barbara Silverman Distinguished Professor of Bioengineering, Biophysics, Electrical Engineering and Computer Science, at University of California, Berkeley. He is founding director of the Biomedical Institute for Global Health Research and Technology (BIGHEART) at the National University of Singapore.
Lee has over 350 peer-reviewed publications and over 40 issued international patents. He is a pioneer in bionanophotonics, plasmonic resonant energy transfer (PRET), rapid photonic PCR, optofluidics, microfluidics for quantitative life sciences, and integrated molecular diagnostics systems. He was elected Fellow of the Royal Society of Chemistry in 2010 and the American Institute of Medical and Biological Engineering in 2012. Lee received the 2009 IEEE William J. Morlock Award in 2009 and the 2010 Ho-Am Prize for his discovery of PRET and the development of quantum nanobiophotonics for optical gene regulations and molecular imaging (photonic RNA switch and gene circuit). His current research interests are quantum electron transfers in living organisms, molecular diagnostics of infectious and neurodegenerative diseases, and in vitro neurogenesis, with a focus both on studying fundamental quantum nanobiology and on solving ill-defined problems of global healthcare.